MHRA symposium reveals no quality control for jabs, fewer inspections, and other dangerous stuff—all delivered courtesy of Microsoft virtual tools
Confidential sites; wide discretion not to inspect favoured manufacturers; law-writing powers; an apparent global agreement to dispense with testing once pharmaceutical products start to be made—the MHRA has spilled the beans. Expert Hedley Rees ...